Biorchestra Co., Ltd.
PrivateLast Round
Series C
Feb 22, 2022
Total Funding Raised
$75.94M
Company Overview
Biorchestra Co., Ltd. operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Series C round in February 2022.
Biorchestra Co., Ltd. is a biotechnology company that develops RNA-based therapeutics and drug delivery systems for the treatment of neurodegenerative and rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorchestra Co., Ltd. Comparables
Compare Biorchestra Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CereCura Nanotherapeutics | 78% | |
| AbbVie | 78% | |
| Aerska | 75% |
For institutional investors. Book with your work email.
Biorchestra Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 22, 2022 | ||||
| Series B Extension | Dec 15, 2020 | ||||
| Series B | Aug 21, 2019 |
For institutional investors. Book with your work email.
Biorchestra Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series C |
| DAYLI Partners | Series B, Series C, Series A |
| STIC Investments | Series C |
| TIPS (Tech Incubator Program for Startup) | Seed |
| LSK Investment | Series B, Series C |
| Quantum Ventures Korea | Series C |
| E&Venture Partners | Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2022
Raised $45M with participation from GS Holdings and STIC Investments.
- Dec 15, 2020
$11M raised with IMM Investment and SBI Investment.
For institutional investors. Book with your work email.
Biorchestra Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biorchestra Co., Ltd.'s valuation, stock price, and market status.
Is Biorchestra Co., Ltd. a public or private company?
Biorchestra Co., Ltd. is a private company.
What is the current stock price of Biorchestra Co., Ltd.?
Biorchestra Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Biorchestra Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biorchestra Co., Ltd. worth (valuation)?
Valuation information for Biorchestra Co., Ltd. is not publicly available.
Can I buy Biorchestra Co., Ltd. stock?
Biorchestra Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biorchestra Co., Ltd.'s last funding round?
Biorchestra Co., Ltd.'s most recent funding round was Series C on February 22, 2022.
Who are the main investors in Biorchestra Co., Ltd.?
Key investors in Biorchestra Co., Ltd. include DAYLI Partners.
Will Biorchestra Co., Ltd. IPO soon?
No public IPO plans have been announced for Biorchestra Co., Ltd..
How can I track Biorchestra Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Biorchestra Co., Ltd.'s shares on secondary markets.